Heart rate modulation by sympathetic nerves in dogs with heart failure

Journal of Veterinary Medical Science

Volumn 64, Issue 11, 2002, Pages 1023-1029

  Uechi, Masami ^a   Shimizu, Akira ^a   Mizuno, Masashi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Catecholamine; Exercise; Mitral regurgitation; Stress

Indexed keywords

CANIS FAMILIARIS;

ADRENALIN; NORADRENALIN;

ADRENERGIC SYSTEM; ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; DOG; DOG DISEASE; FEMALE; HEART; HEART RATE; INNERVATION; MALE; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RUNNING;

ANIMALS; DOG DISEASES; DOGS; EPINEPHRINE; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HEART RATE; MALE; MITRAL VALVE INSUFFICIENCY; NOREPINEPHRINE; PHYSICAL CONDITIONING, ANIMAL; RUNNING; SYMPATHETIC NERVOUS SYSTEM;

EID: 1842843993     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.64.1023     Document Type: Article

References (49)

1. Abraham, W.T., Hensen, J. and Schrier, R.W. 1990. Elevated plasma noradrenaline concentrations in patients with low-output cardiac failure: dependence on increased noradrenaline secretion rates. Clin. Sci. 79: 429-435.
2. 2+ current downregulation in rat atrial myocytes during heart failure. Circ. Res. 89: 607-613.
3. Briest, W., Holzl, A., Rassler, B., Deten, A., Leicht, M., Baba, H.A. and Zimmer, H.G. 2001. Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc. Res. 52: 265-273.
4. Bristow, M.R., Gilbert, E.M., Abraham, W.T., Adams, K.F., Fowler, M.B., Hershberger, R.E., Kubo, S.H., Narahara, K.A., Ingersoll, H., Krueger, S., Young, S. and Shusterman, N. 1996. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 94: 2807-2816.
5. Bristow, M.R. 1998. Why does the myocardium fail? Insights from basic science. Lancet 352 (Suppl 1): SI8-SI14.
6. Calhoun, D.A., Wei, C.C., Zhu, S., Bradley, W.E. and Dell'Italia, L.J. 2001. Enalaprilat blunts reflexive increases in cardiac interstitial norepinephrine in conscious rats. J. Hypertens. 19: 2025-2059.
7. Chang, N.C., Lai, Z.Y., Chan, P. and Wang, T.C. 1997. Left ventricular filling profiles in young white-coat hypertensive patients without hypertrophy. Hypertension 30: 746-752.
8. Chidsey, C.A., Braunwald, E., Morrow, A.G. and Mason, DT. 1963. Myocardial norepinephrine concentrations in man: effects of reserpine and of congestive heart failure. New Engl. J. Med. 269: 653-659.
9. Cohn, J.N., Levine, T.B., Olivari, M.T., Garberg, V., Lura, D., Francis, G.S., Simon, A.B. and Rector, T. 1984. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl. J. Med. 311: 819-823.
10. Colucci, W.S., Packer, M., Bristow, M.R., Gilbert, E.M., Cohn, J.N., Fowler, M.B., Krueger, S.K., Hershberger, R., Uretsky, B.F., Bowers, J.A., Sackner-Bernstein, J.D., Young, S.T., Holcslaw, T.L. and Lukas, M.A. 1996. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 94: 2800-2806.
11. Dash, R., Kadambi, V., Schmidt, A.G., Tepe, N.M., Biniakiewicz, D., Gerst, M.J., Canning, A.M., Abraham, W.T., Hoit, B.D., Liggett, S.B., Lorenz, J.N., Dorn, G.W. 2nd, and Kranias, E.G. 2001. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 103: 889-896.
12. Davis, D., Baily, R. and Zelis, G.J. 1988. Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Am. J. Physiol. 254: 760-766.
13. Dostal, D.E. and Baker, K.M. 1992. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. Am. J. Hypertens. 5: 276-280.
14. Engelhardt, S., Boknik, P., Keller, U., Neumann, J., Lohse, M.J. and Hein, L. 2001. Early impairment of calcium handling and altered expression of junction in hearts of mice overexpressing the beta1-adrenergic receptor. FASEB J. 15: 2718-2720.
15. Engelhardt, S., Hein, L., Wiesmann, F. and Lohse, M.J. 1999. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 96: 7059-7064.
16. Francis, G.S., Cohn, J.N., Johnson, G., Rector, T.S., Goldman, S. and Simon, A. 1993. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 87 (Suppl 6): VI40-VI48
17. Freeman, K., Lerman, I., Kranias, E.G., Bohlmeyer, T., Bristow, M.R., Lefkowitz, R.J., Iaccarino, G., Koch, W.J. and Leinwand, L.A. 2001. Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. J. Clin. Invest. 107: 967-974.
18. Hasking, G.J., Esler, M.D., Jennings, G.L., Burton, D., Johns, J.A. and Korner, PI. 1986. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulaion 73: 615-621.
19. Himura, Y., Felten, S.Y., Kashiki, M., Lewandowski, T.J., Delehanty, J.M. and Liang, C-S. 1993. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation 88: 1299-1309.
20. The IMPROVE Study Group. 1995. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. J. Vet. Intern. Med. 9: 234-242.
21. International Small Animal Cardiac Health Council 1999. Appendix A Recommendations for diagnosis of heart disease and treatment of heart failure in small animals. Textbook of canine and feline cardiology. 2nd ed. (Fox, P.R., Sisson, D., and Moïse, N.S. eds.), W.B. Saunders. Philadelphia.
22. Iwase, M., Uechi, M., Vatner, D.E., Asai, K., Shannon, R.P., Kudej, R.K., Wagner, T.E., Wight, D.C., Patrick, T.A., Ishikawa, Y., Homey, C.J. and Vatner, S.F. 1997. Cardiomyopathy induced by cardiac Gs alpha overexpression. Am. J. Physiol. 272: H585-H589.
23. Kaye, D.M., Lambert, G.W., Lefkovits, J., Morris, M., Jennings, G. and Esler, M.D. 1994. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J. Am. Coll. Cardiol. 23: 570-578.
24. Kirlin, P.C., Kittleson, M.D. and Johnson, L.E. 1987. Neurohumoral and cardiopulmonary response to sustained submaximal exercise in the dog. J. Appl. Physiol. 62: 1040-1045.
25. Krum, H., Sackner-Bernstein, JD., Goldsmith, RL., Kukin, ML., Schwartz, B., Penn, J., Medina, N., Yushak, M., Horn, E., Katz, SD., Levin, HR., Neuberg, GW., DeLong, G. and Packer, M. 1995. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 92: 1499-1506.
26. Kudej, R.K., Iwase, M., Uechi, M., Vatner, D.E., Oka, N., Ishikawa, Y., Shannon, R.P., Bishop, S.P. and Vatner, S.F. 1997. Effects of chronic beta-adrenergic receptor stimulation in mice. J. Mol. Cell. Cardiol. 29: 2735-2746.
27. Leimbach, W.N., Wallin, B.G., Victor, R.G., Aylward, P.E., Sundlöf, G. and Mark, A.L. 1986. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919.
28. Liang, C-S., Fan, T-H.M., Sullebarger, J.T. and Sakamoto, S. 1989. Decreased adrenergic neuronal uptake activity in experimental right heart failure: a chamber-specific contributor to beta-adrenoceptor down-regulation. J. Clin. Invest. 84: 1267-1275.
29. Mabry, T.R., Gold, P.E. and McCarty, R. 1995. Age-related changes in plasma catecholamine responses to chronic intermittent stress. Physiol. Behav. 58: 49-56.
30. McCarty, R., Eisen, G. and Bartholow, C.L. 1991. Plasma catecholamine responses to acute motion stress in laboratory rats. Physiol. Behav. 49: 653-656.
31. McKelvie, R.S., Yusuf, S., Pericak, D., Avezum, A., Burns, R.J., Probstfield, J., Tsuyuki, R.T., White, M., Rouleau, J., Latini, R., Maggioni, A., Young, J. and Pogue, J. 1999. Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study: The RESOLVD Pilot Study Investigators. Circulation 100: 1056-1064.
32. Meredith, I.T., Eisenhofer, G., Lambert, G.W., Dewar, E.M., Jennings, G.L. and Esler, M.D. 1993. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88: 136-145.
33. Neri Serneri, G.G., Boddi, M., Modesti, P.A., Cecioni, I., Coppo, M., Padeletti, L., Michelucci, A., Colella, A. and Galanti, G. 2001. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89: 977-982.
34. Neumann, T. and Heusch, G. 1997. Myocardial, skeletal muscle, and renal blood flow during exercise in conscious dogs with heart failure. Am. J. Physiol. 273: H2452-H2457.
35. Packer, M., Colucci, W.S., Sackner-Bernstein, J.D., Liang, C.S., Goldscher, D.A., Freeman, I., Kukin, M.L., Kinhal, V., Udelson, J.E., Klapholz, M., Gottlieb, S.S., Pearle, D., Cody, R.J., Gregory, J.J., Kantrowitz, N.B., LeJemtel, T.H., Young, S.T., Lukas, M.A. and Shusterman, N.H. for the PRECISE Study Group. 1996. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: The PRECISE trial. Circulation 94: 2793-2799.
36. Patel, M.B., Stewart, J.M., Loud, A.V., Anversa, P., Wang, J., Fiegel, L. and Hintze, T.H. 1994. Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation 84: 2091-2100.
37. Pedersen, H.D., Olsen, L.H., Mow, T. and Christensen, N.J. 1999. Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions. Res. Vet. Sci. 66: 11-17.
38. Pierpoint, G.L., Francis, G.S., DeMaster, E.G., Olivari, M.T., Ring, W.S., Goldenberg, I.F., Reynolds, S. and Cohn, J.N. 1987. Heterogenous myocardial catecholamine concentrations in patients with congestive heart failure. Am. J. Cardiol. 60: 316-321.
39. Port, J.D., Gilbert, E.M., Larrabee, P., Mealey, P., Volkman, K., Ginsburg, R., Hershberger, R.E., Murray, J. and Bristow, M.R. 1990. Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart. Circulation 81: 929-938.
40. Rose, C.P., Burgess, J.H. and Cousineau, D. 1985. Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload. J. Clin. Invest. 76: 1740-1747.
41. Sadoshima, J., Xu, Y., Slayter, H.S. and Izumo, S. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984.
42. Schorb, W., Booz, G.W., Dostal, D.E., Conrad, K.M., Chang, K.C. and Baker, K.M. 1993. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ. Res. 72: 1245-1254.
43. Taniyama, Y., Morishita, R., Nakagami, H., Moriguchi, A., Sakonjo, H., Shokei-Kim, Matsumoto, K., Nakamura, T., Higaki, J. and Ogihara, T. 2000. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102: 246-252.
44. Thomas, J.A. and Marks, B.H. 1978. Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41: 233-243.
45. Uechi, M., Asai, K., Sato, N. and Vatner, S.F. 1998. Voltage-dependent calcium channel promoter restores baroreflex sensitivity in conscious dogs with heart failure. Circulation 98: 1342-1347.
46. Vatner, S.F., Vatner, D.E. and Homcy, C.J. 2000. Beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models. Circ. Res. 86: 502-506.
47. White, W.B. 1986. Assessment of patients with office hypertension by 24-hour noninvasive ambulatory blood pressure monitoring. Arch. Intern. Med. 146: 2196-2199.
48. Woodman, O.L., Amano, J., Hintze, T.H. and Vatner, S.F. 1986. Augmented catecholamine uptake by the heart during hemorrhage in the conscious dog. Am. J. Physiol. 250: H76-H81.
49. Zaretsky, D.V., Zaretskaia, M.V., Kalenikova, E.I. and Grafov, M.A. 2000. Endothelin antagonism does not affect adrenal catecholamine secretion and system haemodynamics during acute stress in Wistar rats. J. Cardiovasc. Pharmacol. 36 (Suppl 1): S374-S376.